From: Clinico-pathological associations and concomitant mutations of the RAS/RAF pathway in metastatic colorectal cancer
KRAS
NRAS
BRAF
PIK3CA
–
0.15 (0.03–0.71), 0.0065**
0.15 (0.04–0.47), 0.0002***
0.47 (0.01–3.33), 0.6993
2.97 (1.27–7.40), 0.0076**
2.18 (0.47–8.03), 0.2517
1.65 (0.50–4.72), 0.3930